| LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation X Sun, TN Phan, SH Jung, SY Kim, JU Cho, H Lee, SH Woo, TK Park, ... Journal of Pharmacology and Experimental Therapeutics 340 (3), 510-519, 2012 | 44 | 2012 |
| In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei TN Phan, KH Baek, N Lee, SY Byun, D Shum, JH No Molecules 25 (8), 1980, 2020 | 22 | 2020 |
| Pyrrolidine-based 3-deoxysphingosylphosphorylcholine analogs as possible candidates against neglected tropical diseases (NTDs): identification of hit compounds towards … AHE Hassan, TN Phan, S Yoon, CJ Lee, HR Jeon, SH Kim, JH No, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 1922-1930, 2021 | 17 | 2021 |
| Low stability and a conserved N-glycosylation site are associated with regulation of the discoidin domain receptor family by glucose via post-translational N-glycosylation TN Phan, EL Wong, X Sun, G Kim, SH Jung, CN Yoon, BS Yang Bioscience, biotechnology, and biochemistry 77 (9), 1907-1916, 2013 | 17 | 2013 |
| Design, Rational Repurposing, Synthesis, In Vitro Evaluation, Homology Modeling and In Silico Study of Sulfuretin Analogs as Potential Antileishmanial Hit Compounds AHE Hassan, TN Phan, Y Choi, S Moon, JH No, YS Lee Pharmaceuticals 15 (9), 1058, 2022 | 13 | 2022 |
| Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies AHE Hassan, K Mahmoud, TN Phan, MA Shaldam, CH Lee, YJ Kim, ... European Journal of Medicinal Chemistry 250, 115211, 2023 | 9 | 2023 |
| Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits H Lee, KH Baek, TN Phan, IS Park, S Lee, J Kim, JH No Biochemical and Biophysical Research Communications 569, 193-198, 2021 | 8 | 2021 |
| Design, synthesis, and repurposing of O6-aminoalkyl-sulfuretin analogs towards discovery of potential lead compounds as antileishmanial agents AHE Hassan, TN Phan, S Moon, CH Lee, YJ Kim, SB Cho, SM El-Sayed, ... European Journal of Medicinal Chemistry 251, 115256, 2023 | 7 | 2023 |
| Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and … M Stampolaki, SR Malwal, N Alvarez-Cabrera, Z Gao, M Moniruzzaman, ... ACS Infectious Diseases 9 (2), 342-364, 2023 | 6 | 2023 |
| Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening TN Phan, KP Park, D Benítez, MA Comini, D Shum, JH No Biochemical and Biophysical Research Communications 637, 308-313, 2022 | 4 | 2022 |
| In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites KH Baek, TN Phan, SR Malwal, H Lee, ZH Li, SNJ Moreno, E Oldfield, ... Biomedicines 10 (3), 670, 2022 | 4 | 2022 |
| Topical application of ALK5 inhibitor A-83-01 reduces burn wound contraction in rats by suppressing myofibroblast population X Sun, YH Kim, TN Phan, BS Yang Bioscience, biotechnology, and biochemistry 78 (11), 1805-1812, 2014 | 4 | 2014 |
| Lipid Transporters: From Bacteria, Protozoa, Fungi and Plants, to Mice and Men S Malwal, KH Baek, TN Phan, H Lee, ZH Li, SNJ Moreno, JH No, ... | 3 | 2021 |
| Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani AHE Hassan, WA Bayoumi, SM El-Sayed, TN Phan, YJ Kim, CH Lee, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2229071, 2023 | 2 | 2023 |
| Defective Ca2+ binding in a conserved binding site causes incomplete N-glycan processing and endoplasmic reticulum trapping of discoidin domain receptors TN Phan, EL Wong, SY Park, HJ Kim, BS Yang Bioscience, biotechnology, and biochemistry 79 (4), 574-580, 2015 | 2 | 2015 |
| LCB 03-0110, a novel pan-DDR/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation X Sun, TN Phan, SH Jung, SY Kim, JU Cho, H Lee, SH Woo, TK Park, ... Journal of Pharmacology and Experimental Therapeutics, 2011 | 2 | 2011 |
| Repurposing of conformationally-restricted cyclopentane-based AKT–inhibitors leads to discovery of potential and more selective antileishmanial agents than miltefosine AHE Hassan, MM Alam, TN Phan, KH Baek, H Lee, SB Cho, CH Lee, ... Bioorganic Chemistry 141, 106890, 2023 | 1 | 2023 |
| Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents AHE Hassan, WA Bayoumi, SM El-Sayed, TN Phan, T Oh, G Ham, ... Pharmaceuticals 16 (11), 1594, 2023 | 1 | 2023 |
| Identification of Leishmania donovani PEX5-PTS1 Interaction Inhibitors through Fluorescence Polarization-Based High-Throughput Screening TN Phan, KHP Park, D Shum, JH No Molecules 29 (8), 1835, 2024 | | 2024 |
| Identification of Novel Flavonoids and Ansa-Macrolides with Activities against Leishmania donovani through Natural Product Library Screening TN Phan, H Lee, KH Baek, JH No Pathogens 13 (3), 213, 2024 | | 2024 |
